Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment.
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment.
复制标题
抑制谷氨酰胺分解与其他疗法相结合,以改善癌症治疗。
DOI:
10.1016/j.cbpa.2021.01.006
复制
发表时间:
2021-06
影响因子:
7.8
通讯作者:
Le A
中科院分区:
文献类型:
--
作者:
Shen YA;Chen CL;Huang YH;Evans EE;Cheng CC;Chuang YJ;Zhang C;Le A
Targeting glutamine catabolism has been attracting more research attention on the development of successful cancer therapy. Catalytic enzymes such as glutaminase (GLS) in glutaminolysis, a series of biochemical reactions by which glutamine is converted to glutamate and then alpha-ketoglutarate, an intermediate of the tricarboxylic acid (TCA) cycle, can be targeted by small molecule inhibitors, some of which are undergoing early phase clinical trials and exhibiting promising safety profiles. However, resistance to glutaminolysis targeting treatments has been observed, necessitating the development of treatments to combat this resistance. One option is to use synergy drug combinations, which improve tumor chemotherapy’s effectiveness and diminish drug resistance and side effects. This review will focus on studies involving the glutaminolysis pathway and diverse combination therapies with therapeutic implications.
登录
查看更多内容
影响因子:
11.2
作者:
Abu Aboud O;Habib SL;Trott J;Stewart B;Liang S;Chaudhari AJ;Sutcliffe J;Weiss RH
通讯作者:
Weiss RH
影响因子:
5.7
作者:
Gross, Matt I.;Demo, Susan D.;Bennett, Mark K.
通讯作者:
Bennett, Mark K.
影响因子:
5.6
作者:
Cha YJ;Kim ES;Koo JS
通讯作者:
Koo JS
DOI:
10.1007/978-3-319-77736-8_5
发表时间:
2018-01-01
期刊:
HETEROGENEITY OF CANCER METABOLISM
影响因子:
--
作者:
Camelo, Felipe;Le, Anne
通讯作者:
Le, Anne
影响因子:
64.8
作者:
Gao, Ping;Tchernyshyov, Irina;Chang, Tsung-Cheng;Lee, Yun-Sil;Kita, Kayoko;Ochi, Takafumi;Zeller, Karen I.;De Marzo, Angelo M.;Van Eyk, Jennifer E.;Mendell, Joshua T.;Dang, Chi V.
通讯作者:
Dang, Chi V.